Sign in

CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company

Corvus Pharmaceuticals, Inc.

Sign in to watch
Ticker
CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464670809
Phone
(650) 900-4520
Business address
901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. S-3MEF Other S-3MEF
  2. 424B5 Offering Prospectus
  3. 8-K Event Other events
  4. 8-K Event Regulation FD disclosure · Other events
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. SCHEDULE 13G Stake Statement of Beneficial Ownership
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 8-K Event Executive or director change
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. 4 Open-market sale Director sold 1,176,332 shares at $4.16 ($4,891,894)
  19. 4 Open-market sale Director sold 1,176,332 shares at $4.16 ($4,891,894)
  20. 4 Derivatives Options or other derivatives

Page 3 of 30 · 584 filings